{ "cik": 1636282, "cik_padded": "0001636282", "entityName": "Spyre Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001636282-26-000020", "filed": "2026-02-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 85721000.0, "net_income": -155203000.0, "operating_cash_flow": -169252000.0, "operating_income": -209562000.0, "stockholders_equity": 715236000.0, "total_assets": 777781000.0, "total_liabilities": 62545000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08744666096225581, "roa_avg2y": -0.2239153408619564, "roa_period_end": -0.19954588759560854, "roe_avg2y": -0.25174041393628754, "roe_period_end": -0.21699550917459412 } }, { "accn": "0001636282-26-000020", "filed": "2026-02-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 89423000.0, "free_cash_flow": -157410000.0, "net_income": -208018000.0, "operating_cash_flow": -157410000.0, "operating_income": -208566000.0, "stockholders_equity": 517804000.0, "total_assets": 608484000.0, "total_liabilities": 90680000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1751241782605001, "roa_avg2y": -0.4377745719177181, "roa_period_end": -0.3418627276970307, "roe_avg2y": -0.5927958735858198, "roe_period_end": -0.4017311569628663 } }, { "accn": "0001636282-26-000020", "filed": "2026-02-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 188893000.0, "free_cash_flow": -99910000.0, "net_income": -338790000.0, "operating_cash_flow": -99910000.0, "operating_income": -242303000.0, "stockholders_equity": 184016000.0, "total_assets": 341859000.0, "total_liabilities": 73288000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3982697156768977, "roa_avg2y": -1.640617622632281, "roa_period_end": -0.9910226145867156, "roe_avg2y": -2.891674241745298, "roe_period_end": -1.8410899052256327 } }, { "accn": "0001636282-26-000020", "filed": "2026-02-19", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 38000.0, "cash": 34863000.0, "free_cash_flow": -80182000.0, "net_income": -83815000.0, "operating_cash_flow": -80144000.0, "operating_income": -84781000.0, "stockholders_equity": 50305000.0, "total_assets": 71144000.0, "total_liabilities": 20839000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.414253056356227, "roa_avg2y": -0.9257745623239632, "roa_period_end": -1.1781035646013718, "roe_avg2y": -1.2486778004558794, "roe_period_end": -1.666136566941656 } }, { "accn": "0001636282-25-000020", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 573000.0, "cash": 15142000.0, "free_cash_flow": -54289000.0, "net_income": -65801000.0, "operating_cash_flow": -53716000.0, "operating_income": -65649000.0, "stockholders_equity": 83941000.0, "total_assets": 109926000.0, "total_liabilities": 25985000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3095626690175242, "roa_avg2y": -0.4846433727130778, "roa_period_end": -0.5985935993304586, "roe_avg2y": -0.588104909886358, "roe_period_end": -0.783895831596002 } }, { "accn": "0001636282-24-000107", "filed": "2024-11-18", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4280000.0, "cash": 90095000.0, "free_cash_flow": -80055000.0, "net_income": -80893000.0, "operating_cash_flow": -75775000.0, "operating_income": -81481000.0, "stockholders_equity": 139832000.0, "total_assets": 161618000.0, "total_liabilities": 21786000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15580124721093885, "roa_avg2y": -0.660887823170657, "roa_period_end": -0.500519744087911, "roe_avg2y": -0.8092820376863936, "roe_period_end": -0.5785013444705075 } }, { "accn": "0001564590-22-008995", "filed": "2023-03-02", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1492000.0, "cash": 19253000.0, "free_cash_flow": -67184000.0, "net_income": -78254000.0, "operating_cash_flow": -65692000.0, "operating_income": -80334000.0, "stockholders_equity": 60081000.0, "total_assets": 83183000.0, "total_liabilities": 23102000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3845142391105341, "roa_avg2y": -0.972570562135693, "roa_period_end": -0.9407451041679189, "roe_avg2y": -1.227427083578414, "roe_period_end": -1.3024749920940064 } }, { "accn": "0001564590-22-008995", "filed": "2022-03-08", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 422000.0, "cash": 22461000.0, "free_cash_flow": -32615000.0, "net_income": -44348000.0, "operating_cash_flow": -32193000.0, "operating_income": -45463000.0, "stockholders_equity": 67428000.0, "total_assets": 77739000.0, "total_liabilities": 10311000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15291866880227797, "roa_avg2y": -0.6628205894661326, "roa_period_end": -0.5704729929636347, "roe_avg2y": -0.7531609561414682, "roe_period_end": -0.6577089636352851 } }, { "accn": "0001564590-21-014021", "filed": "2021-03-18", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 619000.0, "cash": 12817000.0, "free_cash_flow": -25234000.0, "net_income": -27236000.0, "operating_cash_flow": -24615000.0, "operating_income": -27676000.0, "stockholders_equity": 50337000.0, "total_assets": 56077000.0, "total_liabilities": 5740000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11403142817410652, "roa_avg2y": -0.44235829137566995, "roa_period_end": -0.485689320042085, "roe_avg2y": -0.48076396917998643, "roe_period_end": -0.5410731668553946 } }, { "accn": "0001564590-20-005888", "filed": "2020-02-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 212000.0, "cash": 47748000.0, "free_cash_flow": -19052000.0, "net_income": -21698000.0, "operating_cash_flow": -18840000.0, "operating_income": -21906000.0, "stockholders_equity": 62966000.0, "total_assets": 67063000.0, "total_liabilities": 4097000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06506686148079917, "roa_period_end": -0.3235465159626023, "roe_period_end": -0.34459867229933616 } }, { "accn": "0001564590-18-005404", "filed": "2018-03-13", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 208000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001636282-26-000020", "filed": "2026-02-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001636282.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001636282.json" }, "ticker": "SYRE" }